Home › Funds › Frazier Life Sciences Management, L.P. › ZLAB

Frazier Life Sciences Management, L.P. position in ZLAB

Zai Lab Ltd · Health Care

Frazier Life Sciences Management, L.P. reported holding 1,902,320 shares of ZLAB (Zai Lab Ltd) in its Q2 2026 13F filing — a position valued at US$36.1M, representing 0.79% of its reported portfolio and ranking #26 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed ZLAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)1.90M sh
Reported value held$36.14M
Portfolio Weight0.79%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s ZLAB position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in ZLAB in Q1 2025 at 350,000 shares (US$12.6M). The position peaked in Q3 2025 at 1,627,320 shares, worth US$55.1M. Across 6 filings, Frazier Life Sciences Management, L.P. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,902,320 shares valued at US$36.1M. Notable position changes include a 274% increase in Q2 2025 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 350.00K $12.65M New
Q2 2025 1.31M $45.75M Add
Q3 2025 1.63M $55.15M Add
Q4 2025 1.90M $33.56M Add
Q1 2026 1.90M $35.78M Hold
Q2 2026 1.90M $36.14M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZLAB and 13F data

ZLAB (Zai Lab Ltd) is a Health Care company. 14 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$124.9M), TCG Crossover Management, LLC (US$116.6M), RA CAPITAL MANAGEMENT, L.P. (US$109.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZLAB

All ZLAB fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held ZLAB?

Frazier Life Sciences Management, L.P. has disclosed ZLAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Frazier Life Sciences Management, L.P.'s current position in ZLAB?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 1.90M shares of ZLAB (Zai Lab Ltd), valued at $36.14M, representing 0.79% of its reported portfolio and ranking #26.

Has Frazier Life Sciences Management, L.P. been buying or selling ZLAB?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in ZLAB. The position peaked in Q3 2025 at 1.63M shares.

Which other funds hold ZLAB?

Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., among 14 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.